Last updated: 2026-09-16 14:41:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Milestone Pharmaceuticals Inc. (MIST) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.94, with a market capitalisation of $118.20M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.90 to $3.06. This page covers its latest market performance, valuation, price trends and company information.
$118.20M | |
$0.93 | |
$27.95 | |
$0.63 | |
$0.93 | |
337.50K | |
1.51M | |
-- | |
$3.06 | |
$0.90 | |
-- | |
-- |
Milestone Pharmaceuticals Inc. (MIST) is currently trading at $0.94 as of 2026-09-16 14:39:00, up 0.79% ($0.01) from the previous close of $0.93
During today's regular trading session, MIST has traded between $0.63 and $27.95, with a trading volume of 337.50K shares. The current price is near the lower end of today's range.
Over the past seven days, Milestone Pharmaceuticals Inc. (MIST) moved from $1.20 to $0.94, representing a decline of 22.08% ($0.26).
The stock traded between $0.90 and $1.26 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.95 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.6%
MIST is currently trading at $0.94, placing it 1.6% of the way from its 52-week low of $0.90 to its 52-week high of $3.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Milestone Pharmaceuticals Inc. (MIST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.